Category | ID | Name | p-value | FDR (B&H) |
---|---|---|---|---|
GO: Molecular Function | GO:0003723 | RNA binding | 1.11E-10 | 1.18E-07 |
GO: Molecular Function | GO:0017076 | purine nucleotide binding | 5.01E-08 | 2.16E-05 |
GO: Molecular Function | GO:0003735 | structural constituent of ribosome | 6.07E-08 | 2.16E-05 |
GO: Molecular Function | GO:0032555 | purine ribonucleotide binding | 1.48E-07 | 3.93E-05 |
GO: Molecular Function | GO:0032553 | ribonucleotide binding | 2.09E-07 | 4.45E-05 |
GO: Biological Process | GO:0044403 | symbiotic process | 1.16E-35 | 6.36E-32 |
GO: Biological Process | GO:0016032 | viral process | 2.25E-35 | 6.36E-32 |
GO: Biological Process | GO:0044419 | interspecies interaction between organisms | 1.03E-34 | 1.93E-31 |
GO: Biological Process | GO:0051707 | response to other organism | 2.90E-32 | 3.06E-29 |
GO: Biological Process | GO:0009607 | response to biotic stimulus | 3.08E-32 | 3.06E-29 |
GO: Biological Process | GO:0043207 | response to external biotic stimulus | 3.25E-32 | 3.06E-29 |
GO: Biological Process | GO:0098542 | defense response to other organism | 9.85E-32 | 7.95E-29 |
GO: Biological Process | GO:0045087 | innate immune response | 3.58E-31 | 2.53E-28 |
GO: Biological Process | GO:0006952 | defense response | 4.28E-28 | 2.69E-25 |
GO: Biological Process | GO:0002252 | immune effector process | 3.18E-26 | 1.80E-23 |
GO: Cellular Component | GO:0022626 | cytosolic ribosome | 1.48E-15 | 1.01E-12 |
GO: Cellular Component | GO:0005840 | ribosome | 2.06E-10 | 5.84E-08 |
GO: Cellular Component | GO:0044391 | ribosomal subunit | 2.57E-10 | 5.84E-08 |
GO: Cellular Component | GO:0005764 | lysosome | 4.85E-10 | 6.90E-08 |
GO: Cellular Component | GO:0000323 | lytic vacuole | 5.05E-10 | 6.90E-08 |
Mouse Phenotype | MP:0005025 | abnormal response to infection | 5.88E-18 | 1.32E-14 |
Mouse Phenotype | MP:0001793 | altered susceptibility to infection | 7.44E-18 | 1.32E-14 |
Mouse Phenotype | MP:0002406 | increased susceptibility to infection | 3.38E-16 | 4.01E-13 |
Mouse Phenotype | MP:0020185 | altered susceptibility to viral infection | 1.27E-14 | 1.13E-11 |
Mouse Phenotype | MP:0002418 | increased susceptibility to viral infection | 2.17E-14 | 1.55E-11 |
Pathway | 1,269,311 | Interferon Signaling | 1.95E-19 | 3.36E-16 |
Pathway | 1,269,310 | Cytokine Signaling in Immune system | 4.81E-15 | 3.38E-12 |
Pathway | 1,269,312 | Interferon alpha/beta signaling | 5.86E-15 | 3.38E-12 |
Pathway | 1,269,108 | Influenza Infection | 3.72E-14 | 1.61E-11 |
Pathway | 1,268,686 | GTP hydrolysis and joining of the 60S ribosomal subunit | 3.13E-13 | 7.91E-11 |
Disease | C0023893 | Liver Cirrhosis, Experimental | 1.08E-13 | 4.66E-10 |
Disease | C0042769 | Virus Diseases | 1.34E-12 | 2.89E-09 |
Disease | C0021400 | Influenza | 7.78E-12 | 9.47E-09 |
Disease | C0024141 | Lupus Erythematosus, Systemic | 8.76E-12 | 9.47E-09 |
Disease | C0019196 | Hepatitis C | 4.01E-11 | 2.90E-08 |